These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32706452)

  • 1. Farber disease in a patient from China.
    Bao X; Ma M; Zhang Z; Xu Y; Qiu Z
    Am J Med Genet A; 2020 Sep; 182(9):2184-2186. PubMed ID: 32706452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation.
    Bashyam MD; Chaudhary AK; Kiran M; Reddy V; Nagarajaram HA; Dalal A; Bashyam L; Suri D; Gupta A; Gupta N; Kabra M; Puri RD; RamaDevi R; Kapoor S; Danda S
    Clin Genet; 2014 Dec; 86(6):530-8. PubMed ID: 24355074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report.
    Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E
    Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
    Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
    Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations.
    Kim SY; Choi SA; Lee S; Lee JS; Hong CR; Lim BC; Kang HJ; Kim KJ; Park SH; Choi M; Chae JH
    Am J Med Genet A; 2016 Nov; 170(11):3023-3027. PubMed ID: 27411168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
    Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
    Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
    Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
    Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
    Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
    Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
    Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
    Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
    Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis.
    Moghadam SH; Tavasoli AR; Modaresi M; Ziaee V
    J Musculoskelet Neuronal Interact; 2019 Dec; 19(4):521-525. PubMed ID: 31789304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in an atypical presentation of the rare infantile Farber disease.
    Al Jasmi F
    Brain Dev; 2012 Jun; 34(6):533-5. PubMed ID: 21982811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case report of childhood Farber's disease and literature review].
    Bao XH; Tian JM; Ji TY; Chang XZ
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):54-58. PubMed ID: 28072961
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic hematopoietic cell transplantation in Farber disease.
    Ehlert K; Levade T; Di Rocco M; Lanino E; Albert MH; Führer M; Jarisch A; Güngör T; Ayuk F; Vormoor J
    J Inherit Metab Dis; 2019 Mar; 42(2):286-294. PubMed ID: 30815900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system.
    Chedrawi AK; Al-Hassnan ZN; Al-Muhaizea M; Colak D; Al-Younes B; Albakheet A; Tulba S; Kaya N
    Brain Dev; 2012 May; 34(5):400-4. PubMed ID: 21893389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1.
    Brooks BM; Yeh CD; Beers J; Liu C; Cheng YS; Gorshkov K; Zou J; Zheng W; Chen CZ
    Stem Cell Res; 2021 May; 53():102387. PubMed ID: 34088014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family.
    Devi ARR; Gopikrishna M; Ratheesh R; Savithri G; Swarnalata G; Bashyam M
    J Hum Genet; 2006; 51(9):811-814. PubMed ID: 16951918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.
    Yu FPS; Sajdak BS; Sikora J; Salmon AE; Nagree MS; Gurka J; Kassem IS; Lipinski DM; Carroll J; Medin JA
    Am J Pathol; 2019 Feb; 189(2):320-338. PubMed ID: 30472209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype.
    Mahmoud IG; Elmonem MA; Zaki MS; Ramadan A; Al-Menabawy NM; El-Gamal A; Mansour L; Issa MY; Abdel-Hamid MS; Abdel-Hady S; Khalifa I; Ibrahim A; Solyom A; Rolfs A; Selim L
    Clin Genet; 2020 Dec; 98(6):598-605. PubMed ID: 32875576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biochemical abnormalities and genotype in Farber disease.
    Muranjan M; Agarwal S; Lahiri K; Bashyam M
    Indian Pediatr; 2012 Apr; 49(4):320-2. PubMed ID: 22565078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.